D. Holyoake

Definitions and treatment of oligometastatic oesophagogastric cancer according to multidisciplinary tumour boards in Europe

Tiuri E. Kroese, Richard van Hillegersberg, Sebastian F. Schoppmann et al. · European Journal of Cancer · 2022 · 42 citations · Full text

Medicine, Oncology, Surgery +8

Modelling duodenum radiotherapy toxicity using cohort dose-volume-histogram data

D. Holyoake, Marianne Aznar, Somnath Mukherjee et al. · Radiotherapy and Oncology · 2017 · 25 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Superior outcomes of nodal metastases compared to visceral sites in oligometastatic colorectal cancer treated with stereotactic ablative radiotherapy

Séan M. O’Cathail, Thomas J. Smith, Rob Owens et al. · Radiotherapy and Oncology · 2020 · 18 citations · Full text

Medicine, Oncology, Radiation Oncology +17

SPARC, a phase-I trial of pre‐operative, margin intensified, stereotactic body radiation therapy for pancreatic cancer

D. Holyoake, Maxwell Robinson, Michael Silva et al. · Radiotherapy and Oncology · 2020 · 15 citations

Medicine, Oncology, Surgery +12

A phase-I trial of pre‐operative, margin intensive, stereotactic body radiation therapy for pancreatic cancer: the ‘SPARC’ trial protocol

D. Holyoake, Elizabeth C. Ward, Derek Grose et al. · BMC Cancer · 2016 · 13 citations · Full text

Medicine, Oncology, Surgery +17